SCHEMBL7658701

SCHEMBL7658701

O=C(Cl)C1C(=S)C=Cc2ccccc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.38
ALDH1A1 P00352 1/20 0.38
POLB P06746 1/20 0.38
HTR2A P28223 2/20 0.36
CYP2D6 P10635 2/20 0.35
P2RY2 P41231 6/20 0.32
ATM Q13315 2/20 0.32
P2RX1 P51575 1/20 0.31
P2RX3 P56373 1/20 0.31
P2RX4 Q99571 1/20 0.31
P2RX7 Q99572 1/20 0.31
LMNA P02545 2/20 0.31
RET P07949 2/20 0.31
TSHR P16473 1/20 0.31
MAPK1 P28482 1/20 0.31
SCN4A P35499 1/20 0.31
SCN5A Q14524 1/20 0.31
SCN9A Q15858 1/20 0.31
HDAC3 O15379 1/20 0.31
HDAC4 P56524 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11184478 0.84 KDM4E (0.38) KDM4EALDH1A1POLBHTR2ACYP2D6
SCHEMBL3073163 0.84 KDM4E (0.38) KDM4EALDH1A1POLBHTR2ACYP2D6
SCHEMBL11194965 0.84 KDM4E (0.38) KDM4EALDH1A1POLBHTR2ACYP2D6
SCHEMBL11710445 0.82 ATM (0.44) KDM4EALDH1A1POLBHTR2ACYP2D6
SCHEMBL3056750 0.76 ALDH1A1 (0.39) KDM4EALDH1A1POLBCYP2D6P2RY2
SCHEMBL9750458 0.73 ABAT (0.39) KDM4EALDH1A1POLBHTR2AP2RY2
SCHEMBL8797292 0.72 HTR2A (0.43) KDM4EALDH1A1POLBHTR2ACYP2D6
SCHEMBL14916078 0.71 HDAC4 (0.41) ALDH1A1POLBATMLMNATSHR
Citenamide SCHEMBL636661 0.71 ATM (0.57) KDM4EALDH1A1POLBHTR2ACYP2D6
Citenamide SCHEMBL29446009 0.71 ATM (0.57) KDM4EALDH1A1POLBHTR2ACYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6380201-B1 Methods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1F agonists ELI LILLY AND COMPANY 2002-04-30 US disclosed
EP-0749962-B1 6-substituted-1,2,3,4-tetrahydro-9H-carbazoles and 7-substituted-10H-cyclohepta(7,6-B)indoles LILLY CO ELI (US) 2000-11-02 EP disclosed
US-5962473-A Methods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1F ELI LILLY AND COMPANY (US) 1999-10-05 US disclosed
US-5814653-A SUMATRIPTAN FOR RELIEF OF MIGRAINE PAIN AND OTHER DISORDERS ASSOCIATED WITH PEPTIDE EXTRAVASATION DIE TO STUMULATION OF THE TRIGEMINAL GANGLIA; 5-HT 1F AGONISTS ELI LILLY AND COMPANY (US) 1998-09-29 US disclosed
EP-0832650-A2 Use of serotonin 5-HT1F agonists for the prevention of migraine ELI LILLY AND COMPANY (US) 1998-04-01 EP disclosed
WO-1998011895-A1 A METHOD FOR THE PREVENTION OF MIGRAINE ELI LILLY AND COMPANY (US) 1998-03-26 WO disclosed
EP-0824917-A2 Use of a serotonin 5-HTlf agonist in the manufacture of a medicament for treating or ameliorating the symptoms of common cold or allergic rhinitis ELI LILLY AND COMPANY (US) 1998-02-25 EP disclosed
WO-1998006402-A1 TREATMENT OF THE COMMON COLD OR ALLERGIC RHINITIS ELI LILLY AND COMPANY (US) 1998-02-19 WO disclosed
US-5708187-A MIGRANE HEADACHES ELI LILLY AND COMPANY (US) 1998-01-13 US disclosed
EP-0749962-A1 6-substituted-1,2,3,4-tetrahydro-9H-carbazoles and 7-substituted-10H-cyclohepta(7,6-B)indoles ELI LILLY AND COMPANY (US) 1996-12-27 EP disclosed